Design BH3 domain fusion protein as targeting pro-apoptotic self-assembling nanoparticles
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111825
Abstract
No abstract availableKeywords
Funding Information
- Sichuan Provincial Science and Technology Support Program (2018HH0145)
- National Natural Science Foundation of China (81803420)
- National Natural Science Foundation of China (81973226)
- National Natural Science Foundation of China (81773623)
- Overseas Expertise Introduction Project for Discipline Innovation
- Higher Education Discipline Innovation Project (B18035)
This publication has 24 references indexed in Scilit:
- Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancerPharmacological Research, 2016
- Regulated Cell Death: Signaling and MechanismsAnnual Review of Cell and Developmental Biology, 2014
- Programmed Cell Death in Animal Development and DiseaseCell, 2011
- Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial DynamicsDevelopmental Cell, 2011
- Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AMLBlood, 2010
- Tumor resistance to apoptosisInternational Journal of Cancer, 2008
- Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiationGenes & Development, 2003
- The ferritins: molecular properties, iron storage function and cellular regulationBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1996
- Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2Journal of Biological Chemistry, 1996
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980